Back to FARALLON CAPITAL MANAGEMENT, L.L.C. FARALLON CAPITAL MANAGEMENT, L.L.C.

CRBUCRBU
6 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in CARIBOU BIOSCIENCES INC

No. Farallon Capital Management exited its CRBU (Caribou Biosciences) position in Q4 2022. Its Q3 2022 13F listed 896,369 shares worth $9.5M. Farallon Capital Management already held CRBU in its Q3 2021 13F, the earliest on record, and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$70.7M

Total Shares Change

-3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q4
Latest
Exited
0
-100.0%
$00.0%$6.28
0
2022-Q3
Decreased
896,369
-59.3%
$9.5M0.1%$10.42
0
2022-Q2
Decreased
2.2M
-17.1%
$12M0.1%$5.56
0
2022-Q1
Decreased
2.7M
-10.3%
$24.4M0.1%$9.25
0
2021-Q4
Unchanged
3M
0.0%
$44.7M0.2%$14.89
0
2021-Q3
New
3M
-
$70.7M0.3%$23.80
49

Other major holders of CRBU: FMR LLC, BlackRock Finance, Inc., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used